BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 21038539)

  • 1. Autoimmune pancreatitis: an important diagnostic consideration in obstructive jaundice due to a pancreatic mass lesion.
    Swan MP; Bourke MJ; Hopper AD; Kwan V; Williams SJ
    Intern Med J; 2010 Oct; 40(10):720-5. PubMed ID: 21038539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategy for differentiating autoimmune pancreatitis from pancreatic cancer.
    Kamisawa T; Imai M; Yui Chen P; Tu Y; Egawa N; Tsuruta K; Okamoto A; Suzuki M; Kamata N
    Pancreas; 2008 Oct; 37(3):e62-7. PubMed ID: 18815540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dilemmas in autoimmune pancreatitis. Surgical resection or not?
    Hoffmanova I; Gurlich R; Janik V; Szabo A; Vernerova Z
    Bratisl Lek Listy; 2016; 117(8):463-7. PubMed ID: 27546699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase diagnostic accuracy in differentiating focal type autoimmune pancreatitis from pancreatic cancer with combined serum IgG4 and CA19-9 levels.
    Chang MC; Liang PC; Jan S; Yang CY; Tien YW; Wei SC; Wong JM; Chang YT
    Pancreatology; 2014; 14(5):366-72. PubMed ID: 25278306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of serum IgG, IgG4 and carbonic anhydrase II antibodies in distinguishing autoimmune pancreatitis from pancreatic cancer and chronic pancreatitis.
    Talar-Wojnarowska R; Gąsiorowska A; Olakowski M; Dranka-Bojarowska D; Lampe P; Śmigielski J; Kujawiak M; Grzegorczyk J; Małecka-Panas E
    Adv Med Sci; 2014 Sep; 59(2):288-92. PubMed ID: 25194335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of immunohistochemistry for IgG4 in the distinction of autoimmune pancreatitis from peritumoral pancreatitis.
    Dhall D; Suriawinata AA; Tang LH; Shia J; Klimstra DS
    Hum Pathol; 2010 May; 41(5):643-52. PubMed ID: 20149413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diagnostic significance of serum IgG4 levels in patients with autoimmune pancreatitis: a UK study.
    Sadler R; Chapman RW; Simpson D; Soonawalla ZF; Waldegrave EL; Burden JM; Misbah SA; Ferry BL
    Eur J Gastroenterol Hepatol; 2011 Feb; 23(2):139-45. PubMed ID: 21287719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune pancreatitis mimicking pancreatic cancer.
    Robison LS; Canon CL; Varadarajulu S; Eloubeidi MA; Vickers S; Mel Wilcox C
    J Hepatobiliary Pancreat Sci; 2011 Mar; 18(2):162-9. PubMed ID: 20811916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical management of autoimmune pancreatitis.
    Kamisawa T; Satake K
    Adv Med Sci; 2007; 52():61-5. PubMed ID: 18217391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic ductal adenocarcinoma with autoimmune pancreatitis-like histologic and immunohistochemical features.
    Zhang X; Liu X; Joseph L; Zhao L; Hart J; Xiao SY
    Hum Pathol; 2014 Mar; 45(3):621-7. PubMed ID: 24457081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphoplasmacytic sclerosing pancreatitis with obstructive jaundice: a case report and review of the literature.
    Wang G; Zhu H; Yuan CX; Gao Y; Li J; Xue DB; Sun B
    Onkologie; 2009 Sep; 32(8-9):506-8. PubMed ID: 19745596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical utility of immunoglobulin G4 in the evaluation of autoimmune pancreatitis and pancreatic adenocarcinoma.
    Pak LM; Schattner MA; Balachandran V; D'Angelica MI; DeMatteo RP; Kingham TP; Jarnagin WR; Allen PJ
    HPB (Oxford); 2018 Feb; 20(2):182-187. PubMed ID: 29033025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgG4 negative sclerosing cholangitis associated with autoimmune pancreatitis.
    Sewkani A; Kapoor S; Sharma S; Naik S; Debbarma MK; Varshney S
    JOP; 2005 May; 6(3):269-73. PubMed ID: 15883479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of serum IgG4 in the diagnosis and follow up of autoimmune pancreatitis: A systematic literature review and meta-analysis.
    Morselli-Labate AM; Pezzilli R
    J Gastroenterol Hepatol; 2009 Jan; 24(1):15-36. PubMed ID: 19067780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of autoimmune pancreatitis with pancreatic carcinoma remains a challenge to physicians.
    Gong PL; Liu TT; Shen XZ
    J Dig Dis; 2012 May; 13(5):267-73. PubMed ID: 22500789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune pancreatitis: role of endoscopy in diagnosis and treatment.
    Moon SH; Kim MH
    Gastrointest Endosc Clin N Am; 2013 Oct; 23(4):893-915. PubMed ID: 24079796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune pancreatitis and IgG4-related sclerosing cholangitis.
    Takuma K; Kamisawa T; Igarashi Y
    Curr Opin Rheumatol; 2011 Jan; 23(1):80-7. PubMed ID: 21124090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum immunoglobulin G fraction 4 levels in pancreatic cancer: elevations not associated with autoimmune pancreatitis.
    Raina A; Krasinskas AM; Greer JB; Lamb J; Fink E; Moser AJ; Zeh HJ; Slivka A; Whitcomb DC
    Arch Pathol Lab Med; 2008 Jan; 132(1):48-53. PubMed ID: 18181673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Concepts and Diagnosis of IgG4-Related Pancreatitis (Type 1 AIP).
    Kawa S
    Semin Liver Dis; 2016 Aug; 36(3):257-73. PubMed ID: 27466795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of anti-plasminogen binding peptide, anti-carbonic anhydrase II, immunoglobulin G4, and other serological markers for the differentiation of autoimmune pancreatitis and pancreatic cancer.
    Detlefsen S; de Vos JD; Tanassi JT; Heegaard NHH; Fristrup C; Schaffalitzky de Muckadell OB
    Medicine (Baltimore); 2018 Aug; 97(31):e11641. PubMed ID: 30075546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.